Abstract CT017: FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed

Pasi A. Jänne, David Planchard, Jacqulyne Robichaux et al.|Cancer Research|2024

Cited by 25